Board of Directors

• 

  Kenji Nonaka

  M.D. , Ph.D.

• 

  Shinji Ogawa

  Ph.D.

• 

  Hiroyuki Ueno

  Ph.D.

• 

  Ichiro Kodama

• 

  Kazunori Maruyama

  Ph.D.

Auditor

• 

  Takashi Ohno

  CPA, CPTA

Member of Scientific Advisory Board

• 

  Shinya Yamanaka

  Director Emeritus of Center for iPS Cell Research and Application (“CiRA”), Kyoto University / Representative Director of the CiRA Foundation

• 

  Seigo Izumo

  Former Senior Vice President & Global Head, Regenerative Medicine Unit, Takeda Pharmaceutical Company Ltd. / Former Professor of Medicine, Harvard Medical School

• 

  Munehide Matsuhisa

  Director and Professor Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University

Member of Leadership Team

• 

  Kenji Nonaka

  President and CEO

• 

  Shinji Ogawa

  Vice president and CCO/COO

• 

  Ryuichi Tozawa

  Head of Platform Innovation Business Unit

• 

  Tomoyuki Nishimoto

  Head of iPS cell-derived cardiomyocyte (iCM) Therapy Business Unit and CMTO

• 

  Ryo Ito

  Head of iPS cell-derived pancreatic islet cells (iPIC) Business Unit and CMTO

• 

  Kiyoko Nakatani

  Head of Quality Assurance and CQO

• 

  Nobutaka Kikuchi

  Vice President and CMO

• 

  Yu Yoshimura

  Head of Finance and CFO

CEO: Chief Executive Officer, CCO: Chief Compliance Officer, COO: Chief Operating Officer, CMTO: Chief Manufacturing & Technology Officer,
CQO: Chief Quality Officer, CMO: Chief Medical Officer, CFO: Chief Financial Officer